Elevance Health Inc. Common Stock vs FMC Corp — how do they compare? Elevance Health Inc. Common Stock trades at $412.7 (market cap $86.95B), while FMC Corp trades at $8.35 (market cap $1.39B). The key difference: Elevance Health Inc. Common Stock is far larger — about 62.6× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.59%). Which is the better fit depends on your goals.
| ELV | FMC | |
|---|---|---|
Market Cap | $86.95B | $1.39B |
Volume | 782,706 | 4,145,979 |
Sector | Health | Basic Materials |
52-Week High | $426.79 | $30.63 |
52-Week Low | $280.74 | $8.44 |
Enterprise Value | $107.76B | $5.19B |
Dividend Yield | 1.72% | 3.59% |
Typical Hold Time | — | 68 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FMC trades at $8.92, down 1.87% on the day, with a bearish technical outlook and mixed fundamentals. The stock shows weak profitability with a net income margin of -84.83% and negative ROE of -91.47% for 2025, though recent quarterly EPS beats offer some optimism. Analyst consensus is divided with a near-even split between Buy and Hold ratings, and a $14.60 price target suggests significant upside from current levels. Recent news highlights regulatory progress for rimisoxafen in Brazil and a minority equity investment from Tessenderlo Group.
The outlook for FMC hinges on successful deleveraging and product approvals, but high debt and cyclical industry pressures pose substantial risks. While valuation ratios like P/S of 0.34 appear attractive, persistent negative margins and volatile cash flows warrant caution. The stock presents a speculative opportunity for investors betting on a turnaround, but near-term headwinds in the agricultural sector may limit upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →